Status:
COMPLETED
Accuracy of Pulse Oximeters With Profound Hypoxia
Lead Sponsor:
CardiacSense Ltd.
Conditions:
SpO2
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
This project aims to test the accuracy of pulse oximeters during mild, moderate, and severe hypoxia, i.e., a range of arterial HbO2 saturation from 100 down to 70%. A typical study will include at lea...
Detailed Description
After local anesthetic injection, a 22-gauge catheter is inserted in one radial artery. Pulse oximeters are attached to fingers, ears, or flat body surfaces. Subjects are in a comfortable semi-recumbe...
Eligibility Criteria
Inclusion
- The subject is male or female, aged ≥18 and \<50.
- The subject is in good general health with no evidence of any medical problems.
- The subject is fluent in both written and spoken English.
- The subject has provided informed consent and is willing to comply with the study procedures.
Exclusion
- The subject is obese (BMI\>30).
- The subject has a known history of heart disease, lung disease, kidney or liver disease.
- Diagnosis of asthma, sleep apnea, or use of CPAP.
- Subject has diabetes.
- Subject has a clotting disorder.
Key Trial Info
Start Date :
June 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 3 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05322382
Start Date
June 2 2021
End Date
June 3 2021
Last Update
April 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California at San Francisco
San Francisco, California, United States, 94143